Filing Details
- Accession Number:
- 0000899243-23-019370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-21 16:23:57
- Reporting Period:
- 2023-09-19
- Accepted Time:
- 2023-09-21 16:23:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1690585 | Dianthus Therapeutics Inc. | DNTH | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1663607 | Evan Peter Harwin | 200 Barr Harbor Drive, Suite 400 West Conshohocken PA 19428 | Yes | No | Yes | No | |
1802528 | Fairmount Funds Management Llc | 200 Barr Harbor Drive, Suite 400 West Conshohocken PA 19428 | Yes | No | Yes | No | |
1830177 | Tomas Kiselak | 200 Barr Harbor Drive, Suite 400 West Conshohocken PA 19428 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-09-19 | 30,000 | $13.20 | 1,873,833 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Footnotes
- Consists of 30,000 shares of common stock purchased by Fairmount Healthcare Fund II LP ("Fund II").
- Consists of (i) 58,857 shares of common stock held of record by Fairmount Healthcare Fund LP ("Fund I"), (ii) 1,752,830 shares of common stock held of record by Fund II and (iii) 62,146 shares of common stock held of record by Fairmount SPV III, LLC. Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fund I and Fund II and is the Class A Member for Fairmount SPV III, LLC. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.